{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:45:18Z","timestamp":1784306718128,"version":"3.55.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802491, 82173084"],"award-info":[{"award-number":["81802491, 82173084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>DiGeorge Syndrome (DGS) is a rare disease associated with 22q11.2 chromosomal microdeletion, also known as a velocardiofacial syndrome, based on the frequent involvements of the palate, facial, and heart problems. Hematologic autoimmunity is rare in DGS but presents with a refractory course and poor prognosis. Herein, we report a case of partial DGS in a patient with refractory immune cytopenia and autoimmune lymphoproliferative syndrome (ALPS)-like manifestations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>A 10-year-old boy with growth retardation presented initially with a ventricular septal defect at 7 months old, which had been repaired soon after. The patient suffered from thrombocytopenia and progressed into chronic refractory immune thrombocytopenia (ITP) at 30 months old. One year later, the patient developed multilineage cytopenias including thrombocytopenia, neutropenia, and anemia. First-line treatment of ITP, like high-dose dexamethasone and intravenous immunoglobulin, had little or short-term effect on controlling symptoms. Whole-exome sequencing revealed the presence of a <jats:italic>de novo<\/jats:italic> heterozygous 2.520\u2005Mb deletion on chromosome 22q11.21. Moreover, decreased proportion of naive T cells and elevated double-negative T cells were found. The patient was given sirolimus therapy (1.5\u2005mg\/m<jats:sup>2<\/jats:sup>, actual blood concentration range: 4.0\u20135.2\u2005ng\/ml) without adding other immunosuppressive agents. The whole blood cell count was gradually restored after a month, and the disease severity was soothed with less frequency of infections and bleeding events. Decreased spleen size and restrained lymph node expansion were achieved after 3-month sirolimus monotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This case is the first description on the efficacy of sirolimus monotherapy to treat refractory multilineage cytopenias of DGS presented with ALPS-like features.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.1014249","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T05:56:57Z","timestamp":1674021417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features"],"prefix":"10.3389","volume":"10","author":[{"given":"Hao","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/bf00441974","article-title":"Clinical evaluation and course of partial and complete forms of the syndrome","volume":"147","author":"M\u00fcller","year":"1988","journal-title":"Eur J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/bf01995856","article-title":"The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder","volume":"149","author":"M\u00fcller","year":"1989","journal-title":"Eur J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1182\/blood.2018885244","article-title":"Clinical and\u00a0immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center","volume":"133","author":"Giardino","year":"2019","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 Deletion syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1182\/blood-2003-08-2984","article-title":"Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome","volume":"104","author":"Markert","year":"2004","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"671755","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.jaip.2019.03.014","article-title":"Immunophenotype anomalies predict the development of autoimmune cytopenia in 22q11.2 deletion syndrome","volume":"7","author":"Montin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30094","article-title":"Anti-glycoprotein autoantibodies are related to bleeding severity in children with newly diagnosed ITP and very low platelet counts","author":"Dong","year":"","journal-title":"Pediatr Blood Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cei.13620","article-title":"Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: an intriguing challenge","volume":"205","author":"Costagliola","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.3324\/haematol.2016.153411","article-title":"Evolution of disease activity and biomarkers on and off sirolimus in 28 patients with autoimmune lymphoproliferative syndrome","volume":"102","author":"Klemann","year":"2017","journal-title":"Haematologica"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"649182","DOI":"10.3389\/fimmu.2021.649182","article-title":"Primary immunodeficiency in children with autoimmune cytopenias: retrospective 154-patient cohort","volume":"12","author":"Westermann-Clark","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11882-018-0823-5","article-title":". Immune and genetic features of the chromosome 22q11.2 deletion (DiGeorge syndrome)","volume":"18","author":"Kuo","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"B14","first-page":"2326","article-title":"Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome","volume":"28","author":"Davies","year":"2001","journal-title":"J Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/09537104.2021.2002835","article-title":"Refractory immune thrombocytopenia successfully treated with bortezomib in a child with 22q11.2 deletion syndrome, complicated by Evans syndrome and hypogammaglobulinemia","volume":"33","author":"Conti","year":"2022","journal-title":"Platelets"},{"key":"B16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12185-014-1648-1","article-title":"Refractory autoimmune hemolytic anemia in a patient with DiGeorge syndrome treated successfully with plasma exchange: a case report and review of the literature","volume":"100","author":"Damlaj","year":"2014","journal-title":"Int J Hematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091552","article-title":"Characterization of autoimmune thyroid disease in a cohort of 73 paediatric patients affected by 22q11.2 deletion syndrome: longitudinal single-centre study","volume":"13","author":"Ricci","year":"2022","journal-title":"Genes (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/BOR.0000000000000778","article-title":"Double-negative T cells in autoimmune diseases","volume":"33","author":"Li","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fimmu.2019.00447","article-title":"Thymic epithelium abnormalities in DiGeorge and down syndrome patients contribute to dysregulation in T cell development","volume":"10","author":"Marcovecchio","year":"2019","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10875-018-0579-7","article-title":"Lymphocyte apoptosis and FAS expression in patients with 22q11.2 deletion syndrome","volume":"39","author":"Aresvik","year":"2019","journal-title":"J Clin Immunol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1014249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T05:57:01Z","timestamp":1674021421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1014249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":21,"alternative-id":["10.3389\/fped.2022.1014249"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1014249","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"article-number":"1014249"}}